About 1,287,816 results (3,933 milliseconds)

DEFLECT 3: Cerebral Protection and Surprises 30 Days Post-TAVI

http://feedproxy.google.com/~r/Theheartorg/~3/qY9G_unCaRc/845560
May 29, 2015 ... PARIS, FRANCE — A porous cerebral-protection shield placed in the aortic arch during transcatheter aortic-valve implantation (TAVI) and ...

WO2006122168A2 - Self-clearing catheter for clinical implantation ...

https://patents.google.com/patent/WO2006122168A2/en
... infection. A number of approaches designed to prevent and/ or clear obstructions in fluid conduits of medical devices such as CSF shunts have been ...

US9925265B2 - Methods of treating or preventing stent thrombosis ...

https://patents.google.com/patent/US9925265B2/en
A61P7/00 Drugs for disorders of the blood or the extracellular fluid. A61P7 ... Thus the dosages may differ in the periods before implantation, during ...

medical insurance scheme for state employees and pensioners ...

https://groups.google.com/group/bankpensioner/attach/5d29e84aab4c4/GO%28P%29No70-2022-FinDated23-06-2022_45%20%281%29.pdf?part=0.1
Jul 1, 2022 ... discharge. The final package cost is inclusive of pre and post ... Excessive bleeding requiring re- exploration. 12,500. 13,100. 14,400.

US20160140314A1 - Conceivable basal body temperatures and ...

https://patents.google.com/patent/US20160140314A1/en
An ideal menstrual cycle is 28 cycle days (“CD”) long, with ovulation occurring on CD 14, with stretchy, abundant, clear cervical discharge, no PMS, bleeding ...

US6475244B2 - Tunneling device - Google Patents

https://patents.google.com/patent/US6475244B2/en
... fluid accumulation between the dissected tissue and the implant. Using ... blood fluid to collect after implantation. This novel vascular graft device ...

Aortic stenosis in the time of COVID‐19: Development and outcomes ...

https://news.google.com/articles/CBMiNWh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pLzEwLjEwMDIvY2NkLjI5NTUw0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen
Feb 10, 2021 ... ... discharge, minimizing hospital stay, reducing potential staff and ... No patients in the COVID-19 group required blood transfusions due to post ...

US20100247594A1 - Delivery of dry formulations of octreotide ...

https://patents.google.com/patent/US20100247594A1/en
The implants were removed six months after implantation. Blood samples (10 ml) to obtain the serum concentration of octreotide acetate, IGF-1 and GH were ...

WO2015086857A1 - System for flushing a pericardial cavity ...

https://patents.google.com/patent/WO2015086857A1/un
effusion liquid i.e. a mixture of blood and infusion liquid mixed in the ... Blood transfusion has a clearly defined role in the management of ...

US20130045852A1 - Centrifuge separation method and apparatus ...

https://patents.google.com/patent/US20130045852A1/en
... clear fluid called plasma. Plasma is a water solution of salts, metabolites ... mixed with the majority of the white cells and some platelets. The ...

US5514155A - Device for applying pressure to a person's groin ...

https://patents.google.com/patent/US5514155A/en
... bleeding after the discharge of patients from the hospital. These shorts ... clear material to allow the wound area to be visualized well for possible bleeding.

Patient Selection for Ventricular Assist Devices

https://groups.google.com/group/cardiologia-incor-bunker/attach/7ef480069ddac2d4/seleccion_asistencia_ventricular.pdf?part=0.4
More recently, a risk score has been developed to assess perioperative risk of dying prior to hospital discharge after. LVAD implantation. ... White blood cells ...

WO2019126735A1 - Methods and systems for improved collection ...

https://patents.google.com/patent/WO2019126735A1/en
In the absence of bleeding, fluid was collected after 20 minutes of vacuum application. ... Collection and examination of ISF showed it was a clear fluid, with a ...

CN101473073B - Cleaning of semiconductor processing systems ...

https://patents.google.com/patent/CN101473073B/en
In field ion implantation, providing In-Situ Cleaning technology between ... bleeding circulation clean.Each circulation continues about 10 minutes ...

US20090312817A1 - Systems and methods for altering brain and ...

https://patents.google.com/patent/US20090312817A1/en
The brain receives nerve impulses from the spinal cord and 12 pairs of cranial nerves. Some of the cranial nerves are “mixed”, containing both sensory and motor ...

DE60110843T2 - ENERGY-HARDENED INKS AND OTHER ...

https://patents.google.com/patent/DE60110843T2/en
This monomer is a clear fluid at room temperature, has a Molecular weight of ... Table 21 shows that there is a clear dependence between glass ...

US7960335B2 - Octreotide implant having a release agent and uses ...

https://patents.google.com/patent/US7960335B2/en
A61P7/00 Drugs for disorders of the blood or the extracellular fluid. A61P7/04 Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents.

CN102617596B - The black amber terpene of sesterterpene ...

https://patents.google.com/patent/CN102617596B/en
Blood sugar is higher, and the glucose in urine of discharge is more, and urine amount is also more.Lose weight, due to insufficient insulin, body can not ...

US20110229583A1 - Human Medicinal Treatment Typically Using ...

https://patents.google.com/patent/US20110229583A1/en
Adverse side effects of liver transplantation include bleeding, infection ... clear fluid for several days before scabbing over. Once scabbed over, the ...

WO1997021462A1 - Methods and apparatus for anchoring an ...

https://patents.google.com/patent/WO1997021462A1/pt-PT
A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit ... a clear, compatible fluid e . g . an aqueous based fluid such as ...